A detailed history of Sal Trading, LLC transactions in Argenx Se stock. As of the latest transaction made, Sal Trading, LLC holds 1,949 shares of ARGX stock, worth $1.1 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
1,949
Previous 1,949 -0.0%
Holding current value
$1.1 Million
Previous $838,000 26.13%
% of portfolio
2.1%
Previous 1.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$356.01 - $451.55 $106,803 - $135,465
-300 Reduced 13.34%
1,949 $838,000
Q1 2024

May 07, 2024

SELL
$356.95 - $413.29 $535,425 - $619,935
-1,500 Reduced 40.01%
2,249 $885,000
Q4 2023

Feb 14, 2024

SELL
$338.91 - $506.01 $1.49 Million - $2.23 Million
-4,400 Reduced 53.99%
3,749 $1.43 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $3.01 Million - $4.47 Million
8,149 New
8,149 $4.01 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sal Trading, LLC Portfolio

Follow Sal Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sal Trading, LLC with notifications on news.